LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Tisotumab vedotin; First FDA Approved Antibody-drug Conjugate for Cervical Cancer.

Click to show full abstract

Keywords: cancer; approved antibody; vedotin first; tisotumab vedotin; fda approved; first fda

Journal Title: Anti-cancer agents in medicinal chemistry
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended


                Click one of the above tabs to view related content.